CARM1 and colorectal cancer: Mechanistically, RPF2 expression facilitates the binding of the RPF2‐CARM1‐MYCN trio and CARM1's association with the nucleus, which in turn boosts the expression of the downstream protein ABCB1, enhancing colorectal cancer resistance [98].